Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving hundreds of leading biopharmaceutical companies globally:

Queensland Health
Argus Health
Cipla
Medtronic
Healthtrust
McKinsey
Mallinckrodt
Farmers Insurance
UBS

Generated: June 23, 2018

DrugPatentWatch Database Preview

ERGAMISOL Drug Profile

see a sample report or, see our see our flat-rate plans

« Back to Dashboard

Which patents cover Ergamisol, and when can generic versions of Ergamisol launch?

Ergamisol is a drug marketed by Janssen Pharma and is included in one NDA.

The generic ingredient in ERGAMISOL is levamisole hydrochloride. There are three drug master file entries for this compound. Additional details are available on the levamisole hydrochloride profile page.
Summary for ERGAMISOL
Drug patent expirations by year for ERGAMISOL
Medical Subject Heading (MeSH) Categories for ERGAMISOL
Synonyms for ERGAMISOL
(-)-2,3,5,6-Tetrahydro-6-phenylimidazo(2,1-b)thiazole monohydrochloride
(-)-2,3,5,6-Tetrahydro-6-phenylimidazo[2,1-b]thiazole Hydrochloride
(-)-2,5,6-Tetrahydro-6-phenylimidazo[2,1-b]thiazole monohydrochloride
(-)-Tetramisole
(-)-Tetramisole hydrochloride
(-)-Tetramisole hydrochloride, >=99% (GC)
(6S)-6-phenyl-2,3,5,6-tetrahydroimidazo[2,1-b][1,3]thiazole hydrochloride
(6S)-6-phenyl-2,3,5,6-tetrahydroimidazo[2,1-b][1,3]thiazole;hydrochloride
(6S)-6-phenyl-2H,3H,5H,6H-imidazo[2,1-b][1,3]thiazole hydrochloride
(7S)-7-PHENYL-4-THIA-1,6-DIAZABICYCLO[3.3.0]OCT-5-ENE HCL
(S)-(-)-6-Phenyl-2,3,5,6-tetrahydroimidazo[2,1-b]thiazole hydrochloride
(S)-(-)-6-Phenyl-2,3,5,6-tetrahydroimidazo[2,1-b]thiazole hydrochloride; L(-)-2,3,5,6-Tetrahydro-6-phenylimidazo(2,1-b)thiazole hydrochloride; Levamisole hydrochloride
(S)-6-Phenyl-2,3,5,6-tetrahydroimidazo[2,1-b]thiazole hydrochloride
14769-73-4 (Parent)
16595-80-5
24593-45-1
39170-95-1
74191-78-9
AB0013424
AB1009509
AC-23973
AC18787
AC1L1EAA
AK-62825
AKOS015951350
ANW-61085
AS-13370
Ascaridil
BC201679
BMK1-H6
C07906
C11H12N2S.HCl
CAS-16595-80-5
CCG-40301
CHEBI:6433
CHEMBL1770
Citarin L
CS-2372
CTK8B8704
D00750
Decaris
Dekaris
DL9055K809
DSSTox_CID_27518
DSSTox_GSID_47518
DSSTox_RID_82391
DTXSID7047518
EBD2199095
EINECS 240-654-6
Ergamisol (TN)
Ergamisol (TN) (Janssen)
EU-0100690
FT-0625516
HE051629
HE169571
HMS1568F05
HMS1922M11
HY-13666
I013
Imidazo(2,1-b)thiazole, 2,3,5,6-tetrahydro-6-phenyl-, monohydrochloride, (-)-
Imidazo(2,1-b)thiazole, 2,3,5,6-tetrahydro-6-phenyl-, monohydrochloride, (-)- (8CI)
Imidazo(2,1-b)thiazole, 2,3,5,6-tetrahydro-6-phenyl-, monohydrochloride, (6S)-
Imidazo(2,1-b)thiazole, 2,3,5,6-tetrahydro-6-phenyl-, monohydrochloride, (S)-
Imidazo(2,1-b)thiazole, 2,3,5,6-tetrahydro-6-phenyl-, monohydrochloride, L-(-)-
Imidazo[2, 2,3,5,6-tetrahydro-6-phenyl-, monohydrochloride
Imidazo[2, 2,3,5,6-tetrahydro-6-phenyl-, monohydrochloride, (-)-
Imidazo[2, 2,3,5,6-tetrahydro-6-phenyl-, monohydrochloride, (S)-
Imidazo[2, 2,3,5,6-tetrahydro-6-phenyl-, monohydrochloride, L-(-)-
Imidazo[2,1-b]thiazole, 2,3,5,6-tetrahydro-6-phenyl-, monohydrochloride, (6S)-
J-010244
J-521642
KS-00000GHI
KW 2LE-T
KW-2-LE-T
KW-2299
L 9756
L-(-)-2,3,5,6-Tetrahydro-6-phenyl-imidazo(2,1-b)thiazole hydrochloride
L-tetramisol
L-Tetramisole hydrochloride
L(-)-2,3,5,6-Tetrahydro-6-phenylimidazo[2,1-b]thiazole hydrochloride
L0231
LAZPBGZRMVRFKY-HNCPQSOCSA-N
LEV hydrochloride
Levacide
Levadin
Levamisol hydrochloride
Levamisol hydrochloride, VETRANAL(TM), analytical standard
Levamisole (hydrochloride)
Levamisole HCl
Levamisole HCl(Ergamisol)
Levamisole hydrochloride
Levamisole hydrochloride (USP)
Levamisole hydrochloride [USAN:USP]
Levamisole hydrochloride [USAN]
Levamisole Hydrochloride 1.0 mg/ml in Methanol (as free base)
Levamisole hydrochloride for system suitability, European Pharmacopoeia (EP) Reference Standard
Levamisole hydrochloride, European Pharmacopoeia (EP) Reference Standard
Levamisole Hydrochloride, pharmaceutical secondary standard; traceable to USP, PhEur, BP
Levamisole hydrochloride, United States Pharmacopeia (USP) Reference Standard
Levasole
Levomysol hydrochloride
LP00690
LS-80641
MCULE-7118728152
Meglum
MFCD00012675
MLS002153440
MLS002222198
MLS002695941
MolPort-003-666-467
NCGC00094046-01
NCGC00094446-03
NCGC00261375-01
NCGC00263461-01
NE43217
Nemicide
Nilverm forte
Niratic hydrochloride
Niratic-puron hydrochloride
NSC-177023
NSC177023
Prestwick_294
R 12,564
R 12564
R-12,564
R-12564
Ripercol-L
RTR-030849
s1939
SC-26016
SCHEMBL19226
SMR001230807
Solaskil
Spartakon
SPECTRUM1503245
ST24026614
Stimamizol hydrochloride
TL8001274
Tox21_111282
Tox21_111282_1
Tox21_500690
Tramisol
Tramisole
UNII-0NDK265MCV component LAZPBGZRMVRFKY-HNCPQSOCSA-N
UNII-DL9055K809
Worm-chek
Z1550648764

US Patents and Regulatory Information for ERGAMISOL

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Janssen Pharma ERGAMISOL levamisole hydrochloride TABLET;ORAL 020035-001 Jun 18, 1990 DISCN No No ➤ Sign Up ➤ Sign Up ➤ Sign Up
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

see a sample report or, see our see our flat-rate plans

see a sample report or, see our see our flat-rate plans

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

UBS
Moodys
Johnson and Johnson
Colorcon
Harvard Business School
Chinese Patent Office
Medtronic
Deloitte
Cipla

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.